SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,318 | +1.3% | 1,933 | -4.3% | 0.06% | +3.7% |
| Q2 2023 | $231,330 | -3.4% | 2,020 | +16.2% | 0.05% | -5.3% |
| Q1 2023 | $239,549 | +11.3% | 1,738 | +4.6% | 0.06% | +7.5% |
| Q4 2022 | $215,232 | -92.3% | 1,661 | -89.9% | 0.05% | -90.8% |
| Q4 2020 | $2,801,000 | -0.4% | 16,428 | -18.0% | 0.57% | -9.3% |
| Q3 2020 | $2,813,000 | -19.6% | 20,030 | -8.2% | 0.63% | -30.4% |
| Q2 2020 | $3,497,000 | +45.3% | 21,813 | -11.3% | 0.91% | +17.6% |
| Q1 2020 | $2,407,000 | -41.5% | 24,603 | -22.9% | 0.77% | -28.9% |
| Q4 2019 | $4,118,000 | +172.0% | 31,913 | +58.8% | 1.09% | +138.2% |
| Q3 2019 | $1,514,000 | -46.8% | 20,101 | +7.3% | 0.46% | -43.7% |
| Q2 2019 | $2,846,000 | +58.1% | 18,732 | +24.0% | 0.81% | +48.1% |
| Q1 2019 | $1,800,000 | – | 15,101 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |